Notify me when TORONTO DOMINION BANK files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| GBX | GREENBRIER COMPANIES INC | Common Stock without par value | 6% | $86,900,083 | 1,859,223 | The Toronto-Dominion Bank | 31 Dec 2025 | ||
| STOK | Stoke Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 5.8% | $74,571,563 | 3,173,258 | The Toronto-Dominion Bank | 30 Sep 2025 | ||
| PTCT | PTC THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 5.2% | $320,835,809 | 4,138,215 | The Toronto-Dominion Bank | 31 Dec 2025 | ||
| URGN | UroGen Pharma Ltd. | Ordinary Shares, par value NIS 0.01 per share | 4.9% | $45,655,283 | -$17,612,530 | 2,302,334 | -28% | The Toronto-Dominion Bank | 31 Dec 2025 |
| SCHW | The Charles Schwab Corporation | Common Stock, par value $0.01 per share | 0.1% | $105,523,803 | 1,329,350 | The Toronto-Dominion Bank | 10 Feb 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|